TCGC: Clinical Genome ConferenceTCGC: Clinical Genome ConferenceTCGC: Clinical Genome Conference

Now Accepting Speaker Proposals!

The reliability, robustness and reproducibility of next-generation sequencing platforms are no longer questioned, making the unstoppable march of genomics into clinical practices a reality. However, many challenges remain for the successful translation of genomic knowledge into health advances and clinical practice.

Bio-IT World and Cambridge Healthtech Institute are again proud to host the Fourth Annual TCGC: The Clinical Genome Conference, inviting stakeholders impacting clinical genomics to share new findings and solutions for advancing the applications of clinical genome medicine.

TCGC brings together many constituencies for frank and vital discussion of the applications, questions and solutions surrounding clinical genome analysis, including scientists, physicians, diagnosticians, genetic counselors, bioinformaticists, ethicists, regulators, insurers, lawyers and administrators.

Topics addressing successful translation of genomic knowledge and technologies into advancement of clinical utility (medicines and diagnostics) include but are not limited to:

Scientific Investigation and Interpretation
WGS/Exome/Single-Cell Sequencing
Genome Variation
        Deletions and Amplifications
        Gene Expression
        Epigenetic Regulation
        Structural Changes
        Chromosomal Alterations
        Molecular Networks
Drug and Diagnostic Targets
Interpretation and Analysis Pipelines
Case Studies

Clinical Integration and Implementation
Mechanisms to Monitor Genomic Medicine
Determining Clinical Utility
Data Management
Diagnostic Lab Infrastructure
HIT/Data Integration
Reporting Results to Patients/Physicians

Call for Speakers
For a limited time, we are inviting researchers and clinicians applying genome analysis tools in clinical settings, as well as regulators and administrators implementing genomics into the clinic, to submit proposals for platform presentations. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these genomic researchers are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

If you would like to submit a proposal to give a presentation at this meeting, please click here.

All proposals are subject to review by the organizers and Scientific Advisory Committee. 

Deadline for priority consideration: November 21, 2014. 

For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5497

For exhibit & sponsorship opportunities, contact:
Elizabeth Lemelin
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-1342